IDR 228.0
(5.56%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 673.47 Billion IDR | 11.44% |
2022 | 604.32 Billion IDR | 701.91% |
2021 | 75.36 Billion IDR | 0.86% |
2020 | 74.72 Billion IDR | -42.21% |
2019 | 129.29 Billion IDR | -62.54% |
2018 | 345.16 Billion IDR | -1.99% |
2017 | 352.17 Billion IDR | -43.48% |
2016 | 623.13 Billion IDR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 564.79 Billion IDR | -16.14% |
2024 Q2 | 536.32 Billion IDR | -5.04% |
2024 Q3 | 539.56 Billion IDR | 0.6% |
2023 Q3 | 659.41 Billion IDR | -3.91% |
2023 Q4 | 673.47 Billion IDR | 2.13% |
2023 FY | 673.47 Billion IDR | 11.44% |
2023 Q1 | 598.77 Billion IDR | -0.92% |
2023 Q2 | 686.27 Billion IDR | 14.61% |
2022 Q4 | 604.32 Billion IDR | 13.33% |
2022 Q3 | 533.23 Billion IDR | 53.48% |
2022 FY | 604.32 Billion IDR | 701.91% |
2022 Q1 | 92.36 Billion IDR | 22.57% |
2022 Q2 | 347.43 Billion IDR | 276.14% |
2021 Q1 | 49.97 Billion IDR | -33.11% |
2021 FY | 75.36 Billion IDR | 0.86% |
2021 Q4 | 75.36 Billion IDR | 11.1% |
2021 Q3 | 67.83 Billion IDR | 69.29% |
2021 Q2 | 40.06 Billion IDR | -19.83% |
2020 Q2 | 97.53 Billion IDR | -30.48% |
2020 FY | 74.72 Billion IDR | -42.21% |
2020 Q4 | 74.72 Billion IDR | 2.49% |
2020 Q3 | 72.9 Billion IDR | -25.25% |
2020 Q1 | 140.31 Billion IDR | 8.52% |
2019 Q4 | 129.29 Billion IDR | 0.0% |
2019 Q1 | - IDR | -100.0% |
2019 Q2 | 286.04 Billion IDR | 0.0% |
2019 FY | 129.29 Billion IDR | -62.54% |
2018 FY | 345.16 Billion IDR | -1.99% |
2018 Q4 | 345.16 Billion IDR | 0.0% |
2018 Q1 | - IDR | 0.0% |
2018 Q3 | 345.16 Billion IDR | 0.0% |
2017 FY | 352.17 Billion IDR | -43.48% |
2016 FY | 623.13 Billion IDR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
PT Alkindo Naratama Tbk | 941.76 Billion IDR | 28.488% |
PT Inter Delta Tbk | 2.79 Billion IDR | -24022.5% |
PT Suparma Tbk | 984.5 Billion IDR | 31.593% |
PT Tirta Mahakam Resources Tbk | 851.76 Billion IDR | 20.932% |